Cousins Center for Psychoneuroimmunology and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Biol Psychol. 2013 Apr;93(1):150-8. doi: 10.1016/j.biopsycho.2013.01.018. Epub 2013 Feb 11.
Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is believed to play a role in the pathophysiology of depression. To investigate mechanisms that may underlie this effect, we examined several indices of HPA axis function - specifically, diurnal cortisol slope, cortisol awakening response, and suppression of cortisol release following dexamethasone administration - in 26 pre-menopausal depressed women and 23 never depressed women who were matched for age and body mass index. Salivary cortisol samples were collected at waking, 30 min after waking, and at bedtime over three consecutive days. On the third day, immediately after the bedtime sample, participants ingested a 0.5mg dexamethasone tablet; they then collected cortisol samples at waking and 30 min after waking the following morning. As predicted, depressed women exhibited flatter diurnal cortisol rhythms and more impaired suppression of cortisol following dexamethasone administration than non-depressed women over the three sampling days. In addition, flatter diurnal cortisol slopes were associated with reduced cortisol response to dexamethasone treatment, both for all women and for depressed women when considered separately. Finally, greater self-reported depression severity was associated with flatter diurnal cortisol slopes and with less dexamethasone-related cortisol suppression for depressed women. Depression in women thus appears to be characterized by altered HPA axis functioning, as indexed by flatter diurnal cortisol slopes and an associated impaired sensitivity of cortisol to dexamethasone. Given that altered HPA axis functioning has been implicated in several somatic conditions, the present findings may be relevant for understanding the pathophysiology of both depression and depression-related physical disease.
下丘脑-垂体-肾上腺(HPA)轴功能障碍被认为在抑郁症的病理生理学中起作用。为了研究可能导致这种效应的机制,我们检查了 HPA 轴功能的几个指标 - 具体来说,是皮质醇昼夜节律斜率、皮质醇觉醒反应以及地塞米松给药后皮质醇释放的抑制 - 在 26 名绝经前抑郁症女性和 23 名从未抑郁的女性中,这些女性在年龄和体重指数方面相匹配。在连续三天的时间里,收集唾液皮质醇样本,分别在醒来时、醒来后 30 分钟和睡前。第三天,在睡前样本后立即,参与者服用 0.5mg 地塞米松片;然后在第二天醒来和醒来后 30 分钟收集皮质醇样本。正如预测的那样,与非抑郁女性相比,抑郁女性在三天的采样期间表现出更平坦的日间皮质醇节律和地塞米松给药后皮质醇抑制受损。此外,日间皮质醇斜率越平坦,与地塞米松治疗后的皮质醇反应降低相关,无论是所有女性还是单独考虑抑郁女性。最后,自我报告的抑郁严重程度与日间皮质醇斜率越平坦以及抑郁女性地塞米松相关皮质醇抑制越少相关。因此,女性的抑郁症似乎表现为 HPA 轴功能改变,表现为日间皮质醇斜率平坦,皮质醇对地塞米松的敏感性降低。鉴于 HPA 轴功能障碍与几种躯体状况有关,本研究结果可能与理解抑郁症和与抑郁相关的躯体疾病的病理生理学有关。